The mechanistic hypothesis for Alzheimer’s disease applications involves potential synuclein-amyloid-β interactions and overlapping protein aggregation pathways between synucleinopathies and amyloid-related dementias. The gene discussed is SNCA; the disease is synucleinopathy.